Bard Geesaman

Dr. Bard Geesaman serves as Managing Director at MPM Capital. Dr. Geesaman served on the Board of Directors at Chiasma. He serves as Board Member at Genascence. He previously served as Board Member at Maverick Therapeutics. He served as a Board Member at ProterixBio. He served as a Board Member of iOmx Therapeutics. He has been with MPM and associated portfolio companies since 2002. He has broad experience investing, operating, and facilitating business development globally, including in Japan, China, and Israel. Prior to joining MPM, he founded Catalyst Medical Solutions, a medical documentation and billing eHealth company in Boston where he served as the Chief Technology Officer through the company's acquisition. After Catalyst, he joined Centagenetix, an MPM-founded company exploring the genetics of successful aging. He received a B.S. in neuroscience from U.C. Berkeley followed by concurrent degrees from Harvard Medical School and M.I.T. with his Ph.D. work focused on systems and computational neurobiology. He finished his medical training by completing a three-year medical residency at Massachusetts General Hospital. [Source: Public Company Filing]